Peru passed 1 million confirmed cases of coronavirus infection Tuesday, becoming the fifth nation in Latin America to report that number as the region struggles with the pandemic's economic and health effects.
Peru, which has a population of 32 million, was quick to declare lockdown measures in March as the pandemic spread in Europe. But in spite of closing its airports for almost six months and ordering most of its residents to stay at home it has struggled to contain the virus.
Officials said they had recorded 1,000,153 cases as of Tuesday evening.
More than 37,000 people have died from COVID-19 in Peru. That gives the Andean nation the world's second highest per capita death toll from the pandemic, according to data compiled by John Hopkins University.
Peru began to reactivate its economy in August after case numbers peaked in late July, but several factors have made it vulnerable. About 70 per cent of the labor force works in the informal economy and is hard pressed to stay at home.
Water also is scarce in neighborhoods on the periphery of large cities like Lima, which have become focal points for infection.
Many Peruvians lack simple devices that can help them stay at home. According to a recent government study, only 22 per cent of families in working class areas of Peru own a refrigerator. Those who don't must make regular visits to street markets where the virus spreads easily.
As Peru fights the pandemic it has also been rocked by political turmoil. In November President Martin Vizcarra was impeached by congress over bribes that he allegedly took from a construction company while he was a state governor. He was replaced by congressional president Manuel Merino, who lasted less than a week in office as big protests forced him to resign.
The new president, Francisco Sagasti, was appointed by congress and has promised to hold elections next year. His government is currently struggling to purchase coronavirus vaccines from international laboratories and recently blamed the Vizcarra administration for not completing a purchase with Pfizer for 9 million vaccine doses.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.